Thus, E2F1 could promote cancer proliferation via upregulating POLD2 expression in TNBC, indicating that the E2F1-POLD2 signaling pathway is a driver of TNBC proliferation and could be a potential therapeutic target for the treatment of TNBC. This evidence concerns the gene E2F1 and cancer.